life scienc tool diagnost
price month
 close
ep consensu omi ep
exceed conserv estim better revenu
profit factor line ad lower
ep reflect beat off-set lower
oper experi balanc year
estim global solut sale
inter-company sale decreas essenti line plan global
product sale climb vs million
halyard gross margin increas bp plan bp
admin expens higher bp albeit better plan
ebitda margin fell bp bp ahead estim gener
million cash y/i cash reserv stand million
share may rise follow sever quarter disappoint result
manag shift omi share deterior ytd vs
howev view share may rise recent oper
upsid beat admittedli low top-line margin expect
moreov lower top end guidanc rang
midpoint acknowledg updat guid impli less
meaning ramp previou area investor scrutini remain
fundament demand hearten new manag vision note
improv servic level meeting/exceed custom
expect addit one year extens vizient gpo
contract august consolid sale still
remain meaning lever ttm ebitda limit option
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
owen minor healthcar servic compani distribut
medic surgic product acut care custom
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
